Work

Survival Outcomes of Durvalumab in Combination with Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer: Real-World Results from a Single Italian Institution

Year: 2024

Type: article

Study design: Observational Study

Source: Oncology

DOI: 10.1159/000541891

Authors: Margherita Rimini, Silvia Foti, Silvia Camera, Federico Rossari, Francesco Vitiello, Federica Lo Prinzi, Luca Aldrighetti, Francesco De Cobelli, Federica Pedica, Paolo Giorgio Arcidiacono, Mara Persano, Stefano Cascinu, Andrea Casadei-Gardini

Institutions: Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Università Campus Bio-Medico, Campus Bio Medico University Hospital, University of Cagliari

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405105905

FWCI: 2.295

Cites: 29

Cited by: 6

Related to: 10